Clinical trial
Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid…
NCT00278616 · Richard Burt, MD, Other · Withdrawn
Key facts
| NCT number | NCT00278616 |
|---|---|
| Title | Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome |
| Official title | High Dose Cyclophosphamide & CAMPATH-1H With Hematopoietic Stem Cell Transplantation in Patients With Refractory Antiphospholipid Syndrome (APS): A Phase I Trial |
| Lead sponsor | Richard Burt, MD, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | ANTIPHOSPHOLIPID SYNDROME |
| Intervention type | Biological |
| Interventions | Stem Cell Transplantation |
| Enrollment | 0 |
| Start date | Aug 1, 2005 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jan 18, 2006 |
| Last update posted | Apr 11, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: